Advances in sphingolipidoses: CRISPR-Cas9 editing as an option for modelling and therapy
We acknowledge the collaboration of Meg Quint in the proofreading of the manuscript and the team at the Unit of R&D of DGH at INSA-Porto for the agreeable environment provided.
| Autor principal: | |
|---|---|
| Outros Autores: | |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2020
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10400.18/6467 |
| País: | Portugal |
| Oai: | oai:repositorio.insa.pt:10400.18/6467 |